Transcenta Received IND Clearance from NMPA for Its First-In-Class Gremlin1 Targeting ...

Retrieved on: 2023-01-04 05:02:04

Tags for this article:

Click the tags to see associated articles and topics

Transcenta Received IND Clearance from NMPA for Its First-In-Class Gremlin1 Targeting .... View article details on hiswai:

Excerpt

Gremlin1-specific antibodies can effectively control tumor growth in ... TST003 is a high affinity monoclonal antibody targeting Gremlin1, ...

Article found on: www.prnewswire.com